EarningsQ4 2024 Earnings Report

Mirum Pharmaceuticals (MIRM) Q4 2024 Earnings Report

0 Followers

MX:MIRM Q4 2024 EPS Results

Actual EPS-$8.82

Consensus EPS-$4.65

Beat/MissMissed by -$4.18

One Year Ago EPS-$11.34

Actual Revenue$1.79B

Expected Revenue$1.74B

Beat/MissBeat by +$50.54M

YoY Revenue Growth+42.93%

QuarterQ4 2024

Date02/26/2025

TimeAfter Close

Conference CallWednesday, February 26, 2025

MX:MIRM Upcoming Earnings

Mirum Pharmaceuticals's next earnings date is estimated for November 17, 2026, based on past reporting schedules.

MX:MIRM Q4 2024 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 17, 2026	2026 (Q3)	-8.82 / -	0.9	―
Aug 05, 2026	2026 (Q2)	-13.38 / -19.09	-2.161	-783.33% (-16.92)
May 06, 2026	2026 (Q1)	-6.57 / -241.80	-5.401	-4376.67% (-236.40)
Feb 25, 2026	2025 (Q4)	1.01 / -1.80	-8.822	79.59% (+7.02)
Nov 04, 2025	2025 (Q3)	-2.52 / 0.90	-5.401	116.67% (+6.30)
Aug 06, 2025	2025 (Q2)	-5.87 / -2.16	-9.362	76.92% (+7.20)
May 07, 2025	2025 (Q1)	-5.94 / -5.40	-9.723	44.44% (+4.32)
Feb 26, 2025	2024 (Q4)	-4.65 / -8.82	-11.343	22.22% (+2.52)
Nov 12, 2024	2024 (Q3)	-8.08 / -5.40	-10.263	47.37% (+4.86)
Aug 07, 2024	2024 (Q2)	-8.50 / -9.36	-34.929	73.20% (+25.57)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed